Evidence map›Paper›PMID 32512071›Full record

ArticleToxicology and applied pharmacology2020

Activation of the Erk/MAPK signaling pathway is a driver for cadmium induced prostate cancer.

Pritha Dasgupta, Priyanka Kulkarni, Nadeem S Bhat, Shahana Majid, Marisa Shiina, Varahram Shahryari, Soichiro Yamamura, Yuichiro Tanaka, Ravi Kumar Gupta, Rajvir Dahiya and 1 more

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Pritha DasguptaDepartment of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.
Priyanka KulkarniDepartment of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.
Nadeem S BhatDepartment of Surgery, Miller School of Medicine, University of Miami, 4150 Clement Street, Miami, FL 94121, USA.
Shahana MajidDepartment of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.
Marisa ShiinaDepartment of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.
Varahram ShahryariDepartment of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.
Soichiro YamamuraDepartment of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.
Yuichiro TanakaDepartment of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.
Ravi Kumar GuptaDepartment of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA.
Rajvir DahiyaDepartment of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA. Electronic address: rdahiya@ucsf.edu.
Yutaka HashimotoDepartment of Urology, VA Medical Center and University of California San Francisco, School of Medicine, 4150 Clement Street, San Francisco, CA 94121, USA. Electronic address: Yutaka.Hashimoto@ucsf.edu.
University of California, San Francisco · USSan Francisco VA Medical Center · USUniversity of Miami · US

Funding

Genistein and chemotherapy of kidney cancerR01CA196848 · NCI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI YAMAMURA, SOICHIRO · 2016 to 2020
$1.7M
Molecular biomarkers for kidney cancer prognosis using non-coding RNAsR01CA199694 · NCI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI TANAKA, YUICHIRO · 2016 to 2020
$1.7M
Genetic factors for race related prostate cancer.U01CA184966 · NCI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI DAHIYA, RAJVIR · 2015 to 2019
$1.6M
Regulation of c-Myc/HIF pathway in the management of kidney cancerI01BX001123 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI DAHIYA, RAJVIR · 2012 to 2020
–
BLR&D Research Career Scientist Award ApplicationIK6BX004473 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI DAHIYA, RAJVIR · 2019 to 2021
–
Role of genetic biomarkers in clinical assessment of prostate cancerIP1BX001604 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI DAHIYA, RAJVIR, LAU, YUN-FAI CHRIS · 2013 to 2016
–
BLRD VA I01 BX001123BLRD VA IK6 BX004473BLRD VA IP1 BX001604NCI NIH HHS R01 CA196848NCI NIH HHS R01 CA199694NCI NIH HHS U01 CA184966
6 · The paper itself

Abstract

purposeCadmium (Cd) is reported to be associated with carcinogenesis. The molecular mechanisms associated with Cd-induced prostate cancer (PCa) remain elusive. MATERIALS AND

methodsRWPE1, PWR1E and DU 145 cells were used. RT

resultChronic Cd exposure of non-malignant RWPE1 and PWR1E cells promoted cell survival, proliferation and colony formation with inhibition of apoptosis. Even a two-week Cd exposure of PCa cell line (DU 145) significantly increased the proliferation and decreased apoptosis. RT

conclusionThis study demonstrates that Erk/MAPK signaling is a major pathway involved in Cd-induced malignant transformation of normal prostate cells. Understanding these dominant oncogenic pathways may help develop optimal therapeutic strategies for PCa.

Indexed as

CadmiumCarcinogenesisCell Line, TumorCohort StudiesEnzyme ActivationHumansMaleMAP Kinase Signaling SystemProstateProstatic NeoplasmsCadmiumCadmium ToxicityErk/MAPK PathwayProstate Cancer

Identifiers

PMID32512071
PMCPMC7425797
OpenAlexW3032984593

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.